Insider Moves: Acrivon Therapeutics, Inc. — Form 4 Filing Submitted
Acrivon Therapeutics, Inc. has a new Form 4 document logged with the federal securities agency. Investors monitoring executive transactions can review the filing for potential portfolio insights. The notification provides official documentation regarding internal equity shifts.
- Track $ACRV for follow-up insider trading disclosures. - Monitor $ACRV volume alongside future earnings reports. - Watch for potential cluster buying trends in $ACRV filings.